Al-Qerem Walid, Al Bawab Abdel Qader, Hammad Alaa, Ling Jonathan, Alasmari Fawaz
Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
Faculty of Health Sciences and Wellbeing, University of Sunderland, Chester Road, Sunderland SR1 3SD, UK.
Vaccines (Basel). 2022 Mar 9;10(3):410. doi: 10.3390/vaccines10030410.
SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional study based on an online questionnaire for Jordanian adults (n = 915) to determine how individuals who have finished the current vaccination regimen feel about a prospective COVID-19 booster shot and what factors might influence their decision. Almost half of the participants (44.6%) intended to get the booster dose of the COVID-19 vaccine. The most frequently mentioned reasons for participants' reluctance to get the COVID-19 vaccine booster dose were "The benefits of booster dose have not been scientifically proven" (39.8%), followed by "I took the last dose a short time ago, and there will be no need to take the booster dose for at least a year" (24.6%). In turn, "I was infected with COVID-19; thus, I do not require the booster dose" was the least reported reason (13.1%). These findings highlight the considerable hesitancy toward COVID-19 booster immunization among Jordanians, as well as the variables associated with vaccine hesitancy and the most frequently mentioned reasons for hesitancy, which will aid in creating excellent campaigns regarding booster doses.
严重急性呼吸综合征冠状病毒2型（COVID-19）疫苗对于控制严重感染至关重要。然而，随着COVID-19演变成传播性更强的变种，且接种疫苗者体内的血清抗体水平会随着时间稳步下降，突破性感染的可能性增加。这是一项横断面研究，基于针对约旦成年人（n = 915）的在线调查问卷，以确定完成当前疫苗接种方案的个体对未来COVID-19加强针的看法以及哪些因素可能影响他们的决定。近一半的参与者（44.6%）打算接种COVID-19疫苗加强针。参与者不愿接种COVID-19疫苗加强针最常提及的原因是“加强针的益处尚未得到科学证实”（39.8%），其次是“我不久前刚接种了最后一剂，至少一年内无需接种加强针”（24.6%）。相反，“我感染过COVID-19，因此不需要接种加强针”是最少被提及的原因（13.1%）。这些发现凸显了约旦人对COVID-19加强免疫存在相当大的犹豫，以及与疫苗犹豫相关的变量和最常提及犹豫的原因，这将有助于开展关于加强针的有效宣传活动。
